Share Issuance Through Exercise of Stock Options
First written in FY2019-Q3. 10 of 11 entries say "Advanced", first in FY2019. Latest entry: FY2026.
103 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Opening balance 661,200; granted -; exercised 170,493; forfeited 45,200; closing balance 445,507」
Share option exercises continued, with 170,493 shares exercised during the current consolidated fiscal year, 45,200 options forfeited and 445,507 unexercised options remaining at fiscal year-end. - FY2026-H1AdvancedAnnual report
「1 April 2025–30 September 2025 Change in total number of issued shares: 135,732 (Note) Exercise of share options」
During the current interim consolidated accounting period, 135,732 shares were issued through the exercise of share options, increasing stated capital and the capital reserve as well. - FY2024AdvancedAnnual report
「Opening balance 956,600; exercised 142,800; forfeited 34,000; closing balance 779,800」
Stock option exercises continued, with 142,800 shares exercised during the current consolidated fiscal year, 34,000 options forfeited and 779,800 unexercised options remaining at fiscal year-end. - FY2023-Q3AdvancedAnnual report
「Resolution dates: 20 September 2022, 20 October 2022; category and number of grantees: employees of the Company and directors of its subsidiaries, excluding outside directors, 101; number of share options: 287,000; class of shares underlying the share options: common shares; number of shares underlying the share options: 287,000; exercise price per share: ¥1,839; exercise period: from 31 July 2026 to 31 July 2031」
The Company issued 287,000 Fourth Series share options for employees and subsidiary directors, with an exercise period from 31 July 2026 to 31 July 2031. - FY2022-Q1AdvancedAnnual report
「プレミアグループ株式会社 Third Series Share Options (Board of Directors resolution) … Number of share options (units): 150,000 … Exercise period: from 31 July 2025 to 31 July 2029」
The Company resolved to grant 150,000 Third Series share options to employees and directors of subsidiaries, excluding outside directors, with an exercise period from 31 July 2025 to 31 July 2029. - FY2021AdvancedAnnual report
「Opening balance 221,200; exercised 49,000; forfeited –; closing balance 172,200」
Stock option exercises continued, with 49,000 shares exercised during the current consolidated fiscal year, leaving 172,200 unexercised options at fiscal year-end. - FY2021-Q2AdvancedAnnual report
「The number of issued shares increased by 1,000 through the exercise of share options (stock options) between 1 August 2020 and 31 August 2020.」
Stock option exercises continued, increasing the number of issued shares by 1,000 during August 2020. - FY2020-Q3AdvancedAnnual report
「The total number of issued shares increased by 2,400 through the exercise of share options (stock options) between 1 December 2019 and 31 December 2019.」
Stock option exercises continued, increasing the total number of issued shares by 2,400 during December 2019. - FY2020-Q2AdvancedAnnual report
「The total number of issued shares increased by 200 through the exercise of share options (stock options) between 1 September 2019 and 30 September 2019.」
Stock option exercises continued, increasing the number of issued shares by 200 during September 2019. - FY2019AdvancedAnnual report
「Current consolidated fiscal year: 874,800」
Stock option exercises progressed from the partial exercises reported in the previous filing. During the current consolidated fiscal year, 874,800 shares were exercised, leaving 281,200 shares outstanding at fiscal year-end. - FY2019-Q3First statedAnnual report
「The number of issued shares increased by 94,600 shares through exercises between 20 December 2018, the start date of the exercise period for the share options (stock options), and 31 December 2018.」
Through the exercise of stock options, the number of issued shares increased by 94,600 between 20 December and 31 December 2018, while stated capital and the capital reserve each increased by ¥23.650 million.